Search

everythinglearnresearchcommunity

for

Search:↓

Progesterone and testosterone protect brain cells from damage through specific pathways.

The animal models successfully simulated dry eye related to sex steroid deficiency.

Females with pattern hair loss have more occipital involvement than males.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Sex hormones, especially androgens, play a key role in causing acne.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Light and laser therapies show promise for treating Acne Keloidalis Nuchae, but more research is needed.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Testosterone therapy increases bone density in older men with low testosterone levels.

PCOS is influenced by various factors and may be managed by restoring gut health and using new therapies.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Men have more severe COVID-19 outcomes than women.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Current treatments for alopecia show no significant long-term benefits.

Low iron levels may be linked to some types of hair loss in women.